We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA WANTS PENALTIES ON GENERICS THAT MISS DEADLINES
PhRMA WANTS PENALTIES ON GENERICS THAT MISS DEADLINES
May 18, 2004
PhRMA is urging the FDA to implement an administrative penalty to discourage generic firms from missing deadlines for submitting notifications that start the 45-day clock for drugmakers to file patent-infringement lawsuits.